<DOC>
	<DOC>NCT01128439</DOC>
	<brief_summary>This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.</brief_summary>
	<brief_title>Study Estimating the Impact of Prevnar 13â„¢ (13vPnC) on Invasive Pneumococcal Disease</brief_title>
	<detailed_description>No sampling as no subjects are enrolled</detailed_description>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Documented invasive pneumococcal disease (IPD), defined as recovery of an isolate of S pneumoniae from a normally sterile site in a member of the surveillance population.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Pneumococcal conjugate vaccine</keyword>
</DOC>